Ocugen, Inc. current report, 07 June 2022

Ocugen, Inc. 8-K Summary: Annual Meeting Results

Business Context and Reporting Period

This Form 8-K reports the results of Ocugen, Inc.'s 2022 Annual Meeting of Stockholders held virtually on June 7, 2022. The record date for the meeting was April 20, 2022. A total of 107,866,627 shares, representing 50.02% of the outstanding Common Stock, were represented at the meeting.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.

Material Changes and Voting Results

Three proposals were submitted to stockholders. The results are as follows:

  • Item 1: Election of Two Class II Directors
    • Uday B. Kompella, Ph.D.: Elected with 57,233,640 votes For, 8,237,758 Withheld, and 42,395,229 Broker Non-Votes.
    • Marna C. Whittington, Ph.D.: Elected with 61,827,390 votes For, 3,644,008 Withheld, and 42,395,229 Broker Non-Votes.
  • Item 2: Ratification of Independent Registered Public Accountant
    • Ernst & Young LLP was ratified with 102,213,940 votes For, 4,468,884 Against, and 1,183,803 Abstentions. There were no Broker Non-Votes.
  • Item 3: Advisory Approval of Executive Compensation
    • Compensation was approved with 49,150,676 votes For, 14,207,226 Against, and 2,113,496 Abstentions. There were 42,395,229 Broker Non-Votes.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.

Key Facts for Investor Verification

  • Approximately 50% of outstanding shares were represented at the Annual Meeting.
  • Both director nominees were elected, though a significant number of shares (42,395,229) were subject to Broker Non-Votes.
  • The "Say-on-Pay" proposal (Item 3) received significant opposition, with over 14 million votes cast against the advisory compensation approval.
  • Ernst & Young LLP was reappointed as the independent auditor with strong support.